SurgihoneyRO™ antimicrobial wound gel was developed following discoveries made by founder Ian Staples and research groups in Ireland and the UK.
Extensive research has been conducted in the role of Reactive Oxygen® and its natural antimicrobial defence mechanism resulting in SurgihoneyRO™ delivering Reactive Oxygen® to the wound bed and a powerful antimicrobial action.
But where did it start?
It began with an observation of nature. How do honeybees’ succeed in protecting their prized honey hoard to feed them over winter?
Scientists concluded that honey is protected by the production of hydrogen peroxide in nectar. As hydrogen peroxide, a reactive oxygen species, breaks down, free oxygen radicals are formed that are deadly to microbes. Fully ripened honey has a low hydrogen peroxide content and high osmolarity which is enough to stop fermentation.
Natural honey’s vary hugely in their antimicrobial properties and there is little consistency in honey’s antimicrobial effects because there can be no control over nectar source, sugar content and other contaminants in entirely natural products.
Researchers invented a way to precisely control this natural characteristic in honey, the result is SurgihoneyRO™. SurgihoneyRO™ is a bioengineered antimicrobial wound gel that delivers a precisely controlled level of Reactive Oxygen® that is instantly released when it comes into contact with moisture and is sustained for 72 hours.
SurgihoneyRO™ has undergone a unique proprietary process that ensures a standardised and reproducible antimicrobial effect due to the sustained release of Reactive Oxygen® when it is diluted with wound exudate. It is not reliant on a single floral source for its potency and can be produced in large quantities.
SurgihoneyRO™ is sourced from honey with stringent controls to make sure it is ultra-pure and free from antibiotics and pesticides. Gamma irradiation is used to destroy any potential microorganisms without loss of its antimicrobial potency.